(Q34560423)

3 August 2017

1 reference

title

Antipsychotic withdrawal symptoms: phenomenology and pathophysiology (English)

1 reference

3 August 2017

1 reference

Dilsaver SC

1

1 reference

3 August 2017

Alessi NE

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 March 1988

1 reference

Acta Psychiatrica Scandinavica

3 August 2017

published in

1 reference

3 August 2017

volume

77

1 reference

3 August 2017

issue

3

1 reference

3 August 2017

page(s)

241-246

1 reference

Drug dependence as a criterion for differentiation of psychotropic drugs.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Withdrawal from neuroleptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Medical effects of abrupt neuroleptic withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Results of simultaneous abrupt withdrawal of ataraxics in 500 chronic psychotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Stages of onset of schizophrenic psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Anti-muscarinic properties of neuroleptics and drug-induced Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Antidepressants and the Muscarinic Acetylcholine Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Anticholinergic activity of two tricyclic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Effects of dopaminergic drugs and acute medial forebrain bundle lesions on striatal acetylcholine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Evidence for a cholinergic role in haloperidol-induced catalepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

Development of supersensitivity of apomorphine-induced increases in acetylcholine levels and stereotypy after chronic fluphenazine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1988.TB05116.X

10.1111/J.1600-0447.1988.TB05116.X

21 January 2018

Identifiers

DOI

1 reference

release_dne3axtnbrbuxbi6jrdufzrwvy

3 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/dne3axtnbrbuxbi6jrdufzrwvy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference